MedPath

Use of Ayurvedic Manjishtadi Lotion to Prevent and Treat Striae Gravidarum (stretch marks of pregnancy)

Phase 2/3
Not yet recruiting
Conditions
Primi-gravida
Registration Number
CTRI/2025/06/089331
Lead Sponsor
Dr Pranali Laxman Gawade
Brief Summary

The Present Title "An open labelled clinical trial on preventive and curative effect of Manjishtadi Lotion on Kikkisa w.s.r. to Striae Gravidarum" is a clinical study with total number of 40 registered Primi-gravida divided into 2 groups each 20.

Group A will have 20 Primi-gravida in their 5th and 6th month of pregnancy and Group B will have 20 in their 6th and 7th month of pregnancy.

Group A will be Preventive group and Group B will be Curative group. Both groups will be administered with local application of Manjishtadi Lotion on abdomen thrice a day for two months. Assessment will be done with subjective and objective criteria on 30th and 60th day. Follow up will be on 90th day.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • 1.Primi-gravida with gestational age between 16th to 24th week and having no any symptoms of Kikkisa for Preventive Group.
  • 2.Primi-gravida with gestational age between 20th to 28th week and having one or more symptoms or clinical features of Kikkisa for Curative Group.
  • 3.Age 18-35 years primi-gravida.
Exclusion Criteria
  • 1.Multi-gravida.
  • 2.Polyhydramnios and Twin pregnancy 3.Pregnancy with huge uterine fibroid or ovarian cyst.
  • 4.Pregnant woman suffering from any other skin disease.
  • 5.Pregnant woman suffering from any systemic illness.
  • 6.Pregnant woman above 40 years of age.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Group A for prevention of Straie GravidarumGroup A will be assessed for 8 weeks (treatment duration 16th to 24th week of pregnancy) Group B will be assessed for 8 weeks (treatment duration 20th to 28th week of pregnancy)
Group B to cure Straie GravidarumGroup A will be assessed for 8 weeks (treatment duration 16th to 24th week of pregnancy) Group B will be assessed for 8 weeks (treatment duration 20th to 28th week of pregnancy)
Secondary Outcome Measures
NameTimeMethod
Group A Striae Gravidarum does not appear at allGroup B Cure of the Striae Gravidarum & reduction in the symptoms kandu daha twaka bheda vaivarnya Rekha swaroop twaka sankocha

Trial Locations

Locations (1)

OPD and IPD, Department of Prasuti Tantra Evum Stree Roga

🇮🇳

Belgaum, KARNATAKA, India

OPD and IPD, Department of Prasuti Tantra Evum Stree Roga
🇮🇳Belgaum, KARNATAKA, India
Dr Pranali Laxman Gawade
Principal investigator
09518959948
plgawade97@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.